Real-time autoshimming for echo planar timecourse imaging.

Functional MRI of language in aphasia: a review of the literature and the methodological challenges. Neuropsychol Rev (2007) 1.68

Magnetic field shift due to mechanical vibration in functional magnetic resonance imaging. Magn Reson Med (2005) 1.48

Echo-planar imaging with prospective slice-by-slice motion correction using active markers. Magn Reson Med (2011) 1.24

Reproduction of motion artifacts for performance analysis of prospective motion correction in MRI. Magn Reson Med (2013) 1.03

Combined prospective and retrospective correction to reduce motion-induced image misalignment and geometric distortions in EPI. Magn Reson Med (2012) 0.97

Optimization of static magnetic field homogeneity in the human and animal brain in vivo. Prog Nucl Magn Reson Spectrosc (2009) 0.91

Real-time dynamic frequency and shim correction for single-voxel magnetic resonance spectroscopy. Magn Reson Med (2012) 0.91

Dynamic multi-coil technique (DYNAMITE) shimming for echo-planar imaging of the human brain at 7 Tesla. Neuroimage (2014) 0.88

Whole-brain three-dimensional T2-weighted BOLD functional magnetic resonance imaging at 7 Tesla. Magn Reson Med (2013) 0.86

Spectroscopic imaging with prospective motion correction and retrospective phase correction. Magn Reson Med (2011) 0.85

Discriminating brain activity from task-related artifacts in functional MRI: fractal scaling analysis simulation and application. Neuroimage (2007) 0.81

B0 magnetic field homogeneity and shimming for in vivo magnetic resonance spectroscopy. Anal Biochem (2016) 0.79

Enhanced positive-contrast visualization of paramagnetic contrast agents using phase images. Magn Reson Med (2009) 0.79

Subject-specific models of susceptibility-induced B0 field variations in breast MRI. J Magn Reson Imaging (2012) 0.78

Correction of B 0-induced geometric distortion variations in prospective motion correction for 7T MRI. MAGMA (2016) 0.77

Real-time measurement and correction of both B0 changes and subject motion in diffusion tensor imaging using a double volumetric navigated (DvNav) sequence. Neuroimage (2015) 0.77

Motion correction in MRI of the brain. Phys Med Biol (2016) 0.75

Quantitative assessment of the susceptibility artefact and its interaction with motion in diffusion MRI. PLoS One (2017) 0.75

Model-based iterative reconstruction for single-shot EPI at 7T. Magn Reson Med (2017) 0.75

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90

Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71

Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10

Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66

The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain (2006) 4.07

Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85

The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA (2010) 3.58

Testing the right target and right drug at the right stage. Sci Transl Med (2011) 3.55

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53

Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40

Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain (2012) 3.08

Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage (2005) 3.06

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68

Magnetic resonance elastography of the brain. Neuroimage (2007) 2.59

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain (2007) 2.58

Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am (2003) 2.43

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain (2012) 2.43

Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med (2009) 2.43

3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40

Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol (2011) 2.40

Association of ambulatory blood pressure with ischemic brain injury. Hypertension (2007) 2.39

Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage (2010) 2.33

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32

Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27

Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25

Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol (2010) 2.16

Methodological considerations for measuring rates of brain atrophy. J Magn Reson Imaging (2003) 2.16

Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13

A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol (2012) 2.09

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03

Brain injury biomarkers are not dependent on β-amyloid in normal elderly. Ann Neurol (2013) 2.03

Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology (2006) 2.01

Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology (2012) 2.01

Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging (2007) 2.00

Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage (2008) 1.98

Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. AJNR Am J Neuroradiol (2003) 1.96

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94

Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage (2010) 1.94

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93

Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol (2008) 1.93

Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93

Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging (2006) 1.92

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91

Rates of cerebral atrophy differ in different degenerative pathologies. Brain (2007) 1.90

Non-stationarity in the "resting brain's" modular architecture. PLoS One (2012) 1.90

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med (2009) 1.90

Measurement of MRI scanner performance with the ADNI phantom. Med Phys (2009) 1.85

Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol (2007) 1.84

Spherical navigator echoes for full 3D rigid body motion measurement in MRI. Magn Reson Med (2002) 1.83

Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. Neuroimage (2007) 1.83

Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79

Ecology of the aging human brain. Arch Neurol (2011) 1.78

Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76

Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography. J Magn Reson Imaging (2011) 1.72

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage (2009) 1.71

3D high temporal and spatial resolution contrast-enhanced MR angiography of the whole brain. Magn Reson Med (2008) 1.70

Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke (2009) 1.70

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69

Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging (2010) 1.69

Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage (2010) 1.69

Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci (2008) 1.69

Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol (2013) 1.68

Diagnostic neuroimaging across diseases. Neuroimage (2011) 1.66

Imaging correlates of posterior cortical atrophy. Neurobiol Aging (2006) 1.65

Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain (2008) 1.64

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol (2007) 1.57

Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp (2010) 1.55

Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage (2011) 1.54

Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage (2009) 1.53

Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. Brain (2006) 1.51

The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol (2008) 1.51

Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet (2012) 1.51

Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int (2004) 1.50

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin (2013) 1.49

Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage (2011) 1.48

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2005) 1.47

TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol (2014) 1.47

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging (2009) 1.46